Alle Fälle anzeigen
UPC APP 29243/2025
—·EP2401365: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION
- Verfahrensdetails
- Status—VerfahrensartVerfahrensantragKategorieAkteneinsicht (RoP262)
- Parteien
- Beklagte
- BioNTech SE
- BioNTech Manufacturing GmbH
- BioNTech Manufacturing Marburg GmbH
- BioNTech Innovative Manufacturing Services GmbH
- BioNTech Europe GmbH
- Pfizer Manufacturing Belgium NV
- Pfizer SAS
- Pfizer AB
- Pfizer, Inc.
Vertreter: Christine Kanz (Hoyng Rokh Monegier) - Division
- Munich LD
- Richter
- Andras Kupecz · Judge-Rapporteur (Munich Local Division, Panel 2)
- Technology
- Biotechnology
- Sprache
- —
- Erste Entscheidung
- 15. Juli 2025
Entscheidungen
- 2025-07-15Application RoP262A
The Munich Local Division issued a procedural order on BioNTech/Pfizer's R. 262A RoP application to extend confidentiality protection to certain information in the Promosome LLC v. BioNTech/Pfizer infringement proceedings concerning EP 2 401 365. The court largely denied the extension, finding that the information was already covered by an existing confidentiality order of 10 March 2025.
Rechtsfragen:Extension of confidentiality protection (R. 262A RoP)Existing confidentiality order coverageAccess restrictions in infringement proceedings
Dokumente
- 6BE74F1C08BB75D0B760FB1F30966A40_en.pdf2025-07-15EN